Eilmeldung
INED Freezes TMC Bank Accounts with Rs 440 Crore Amid Money Laundering ProbeKR담양에 호우주의보 발효…계곡물·하천 범람 등 사고 유의CN中聯油脂致癌油案延燒 檢方追查污染源釐清責任CN美伊交火升級 川普揚言痛擊伊朗CN賴清德指示嚴辦中聯油脂食安事件,籲修食安法提升保障CN賴清德示警國人避免非必要赴中行程:近年已有374人失聯或自由受限ARإيران توعد بـ"عقاب شديد" رداً على الضربات الأمريكية في الخليجKR금강홍수통제소, 용수천 세종시 도암교 지점에 홍수경보 발령INTLTrump's Video Share Sparks Islamophobia Fears for Somali Students in MinnesotaRUСтудентка в Индии укусила директора колледжа, пытавшегося ее изнасиловатьINED Freezes TMC Bank Accounts with Rs 440 Crore Amid Money Laundering ProbeKR담양에 호우주의보 발효…계곡물·하천 범람 등 사고 유의CN中聯油脂致癌油案延燒 檢方追查污染源釐清責任CN美伊交火升級 川普揚言痛擊伊朗CN賴清德指示嚴辦中聯油脂食安事件,籲修食安法提升保障CN賴清德示警國人避免非必要赴中行程:近年已有374人失聯或自由受限ARإيران توعد بـ"عقاب شديد" رداً على الضربات الأمريكية في الخليجKR금강홍수통제소, 용수천 세종시 도암교 지점에 홍수경보 발령INTLTrump's Video Share Sparks Islamophobia Fears for Somali Students in MinnesotaRUСтудентка в Индии укусила директора колледжа, пытавшегося ее изнасиловать
Newsgather
BackColossal Biosciences: From Mammoth Genome Research to a $10 Billion Startup
Colossal Biosciences: From Mammoth Genome Research to a $10 Billion Startup
In Entwicklung
TOI World23.06.2026Technik4 dk okumaIndia

Colossal Biosciences: From Mammoth Genome Research to a $10 Billion Startup

Auf einen Blick

  • Colossal Biosciences, a startup aiming to revive extinct species like the woolly mammoth using genetic engineering, has secured significant funding and a high valuation despite having no commercial products.
  • The company focuses on introducing mammoth traits into Asian elephants and exploring artificial womb technology, with potential applications in conservation and ecological restoration, though facing scientific and ethical skepticism.

KI-generierte Zusammenfassung

Warum es wichtig ist

Colossal Biosciences, founded in 2021, aims to revive extinct species using genetic engineering, with the woolly mammoth as its primary focus. The company has attracted significant investment despite lacking commercial products.

Schriftgröße

PC: Forbes

A few years ago, the idea of reviving extinct animals sat closer to speculative science fiction than anything investors would normally put money behind. Yet it has steadily been pulled into boardrooms, laboratories, and funding rounds at a scale that now feels difficult to ignore. At the centre of it is Colossal Biosciences, a company built around the notion that genetic engineering might one day recreate versions of lost species, beginning with the woolly mammoth. Its chief executive, Ben Lamm, has become one of the more unusual figures in biotech, part tech entrepreneur, part promoter of long-horizon biology. The company has no commercial product tied to its core ambition, no living mammoth, and no revenue from de-extinction work. Still, it has attracted billions in valuation and hundreds of millions in funding, driven by the belief that its science could eventually reach far beyond the Arctic animals it is known for.

Colossal Biosciences: From mammoth genome research to a $10 billion startup

The origin of Colossal Biosciences traces back to an encounter between Ben Lamm and Harvard geneticist George Church. Church had already spent years working on ancient DNA, including attempts to reconstruct the woolly mammoth genome from remains preserved in Arctic ice. His work had existed mostly within academic research circles, with limited expectation that it would move into commercial territory. Lamm came from a very different world, having built and sold several technology companies. As reported by Forbes, one of his previous ventures, Hypergiant, an AI-focused software firm, was later acquired by Thrive Capital in 2023 for an undisclosed sum. The meeting between the two eventually led to the creation of Colossal in 2021, backed initially with around $15 million in seed funding. Church’s involvement in mammoth genetics dated back more than a decade before the company existed. Lamm, by contrast, saw the possibility of turning that research into a platform company built around genetic engineering tools rather than a single scientific goal.

Funding, valuation and a business built on future outcomes

The company expanded quickly through successive funding rounds, drawing support from venture capital firms and investors associated with large private investment groups. As reported by Forbes, the company raised around $200 million in 2025, led by TWG Global, placed Colossal at a valuation of roughly $10.2 billion. That valuation has made Lamm a billionaire on paper, with estimates placing his net worth at about $3.7 billion. In total, the company has raised approximately $435 million. Despite this, it does not yet generate revenue from its de-extinction programme. Instead, parts of its scientific work have been separated into spinouts, including Form Bio, launched in 2022 as a computational biology platform, and Breaking, a biological recycling venture formed in 2024. The company’s structure reflects a long development cycle, where commercial returns are expected to come from tools, licensing and adjacent technologies rather than the immediate creation of extinct animals.

What the woolly mammoth project actually involves

The goal of Colossal’s best-known project is not a precise recreation of the woolly mammoth. Instead, researchers are working with Asian elephant DNA and introducing genetic traits identified in mammoth genomes recovered from frozen remains. These changes focus on characteristics linked to cold adaptation, including hair growth, fat distribution and other physiological features. Early progress has involved multiplex gene editing across more than 20 genomic sites. The intention is to produce an elephant-based animal that can survive in colder environments resembling those once inhabited by mammoths, rather than resurrecting an identical prehistoric species. Artificial womb research forms another strand of the work. Elephants present practical challenges due to their long gestation periods and reproductive biology, prompting exploration of lab-based embryo development systems that could shorten timelines for experimentation.

Ecological role of woolly mammoths and Colossal Biosciences’ conservation and de-extinction vision

Supporters of the project often point to the ecological role mammoths once played in shaping northern landscapes. Their movement and grazing patterns are believed to have influenced grassland preservation and soil conditions, with some researchers suggesting that similar animals today could affect permafrost stability and carbon release. Reportedly, Colossal has said it is in discussions with two governments about potential biodiversity-related contracts, including one island nation. One proposed project involving an endangered species could cost around $350 million over decades, with uncertain outcomes if pursued through conventional conservation methods. The company has suggested that genetic engineering could shorten that timeline, though this raises scientific and ethical debate.

Criticism and questions over environmental release

Outside the company, scepticism is strong. Some geoscientists and conservation experts question whether engineered animals can meaningfully restore ecosystems that have changed significantly since extinction events occurred. Others argue that releasing genetically modified organisms into open environments introduces risks that are not yet fully understood. Karl Flessa, a professor of geosciences at the University of Arizona, has described the idea of bringing back mammoth-like animals as misguided, pointing to concerns about ecological mismatch and uncertain climate benefits. He has also questioned whether such animals would survive in environments already under pressure from warming temperatures. Within Colossal, chief science officer Beth Shapiro has acknowledged the uncertainty while arguing that traditional conservation approaches alone may not be sufficient given the speed of environmental change. Roughly 46,300 species are currently considered threatened with extinction according to the International Union for Conservation of Nature.

Worauf zu achten ist

KI-Ausblick — Möglichkeiten, keine Fakten

  • Colossal Biosciences spinouts like Form Bio and Breaking will generate revenue.

    Wahrscheinlich · Mittelfristig

Offene Fragen

  • Can engineered animals restore changed ecosystems?
  • What are the risks of releasing GMOs?
  • Will mammoth-like animals survive warming climates?

Verwandte Themen

This article was originally published by TOI World.

Ähnliche Meldungen

How Shrimp Shells Are Being Turned Into ‘Carbon Negative’ Fuel, Food and Construction Materials
In Entwicklung·3 sa önce

How Shrimp Shells Are Being Turned Into ‘Carbon Negative’ Fuel, Food and Construction Materials

Scientists in Singapore have developed a process to convert shrimp shells and other organic waste into hydrogen fuel, protein for aquaculture feed, and calcium carbonate for construction. The technology, developed at Nanyang Technological University, aims to be carbon-negative by removing more CO2 than it produces, offering a dual solution for waste reduction and cleaner energy.

TOI World
Mehr zu diesem ThemaColossal Biosciences